Close

Analyst Ratings for NGM Biopharmaceuticals (NGM) [Sells]

NGM Rating Summary

NGM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NGM
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $1.55 (+0.6%) * Over Last 12-Mos
Rating Score: 3 / 10   Percentile Rank: 26%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details